• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类干细胞来源的慢性药物暴露心脏模型。

Human Stem Cell-Derived Cardiac Model of Chronic Drug Exposure.

作者信息

Nunes Sara S, Feric Nicole, Pahnke Aric, Miklas Jason W, Li Mark, Coles John, Gagliardi Mark, Keller Gordon, Radisic Milica

机构信息

Toronto General Research Institute, University Health Network, 101 College Street Toronto, Ontario, Canada M5G 1L7.

Heart & Stroke/Richard Lewar Centre of Excellence, University of Toronto, 101 College Street, MaRS Third Floor, Room 902, Toronto, Ontario, Canada M5G 1L7.

出版信息

ACS Biomater Sci Eng. 2017 Sep 11;3(9):1911-1921. doi: 10.1021/acsbiomaterials.5b00496. Epub 2016 May 10.

DOI:10.1021/acsbiomaterials.5b00496
PMID:33440549
Abstract

Animal models have been instrumental in providing insight into the molecular basis of disease. While such information has been successfully applied to the study of human disease, this translation would be significantly strengthened by the availability of models based on human cells. This would be particularly important for cardiovascular disease, as the physiology of human cardiomyocytes (CMs) differs significantly from rodents. Here, we have generated a three-dimensional human engineered cardiac tissue, termed biowire, from human embryonic stem cell-derived CMs to investigate the effects of chronic (7 day) treatment with isoproterenol, endothelin-1, or angiotensin II. We show that biowires chronically treated with either isoproterenol, endothelin-1, or angiotensin II have disrupted myofibril alignment and significantly reduced force of contraction. Isoproterenol-treated biowires have upregulated brain natriuretic peptide and atrial natriuretic peptide gene expression. Endothelin-1 and angiotensin II-treated biowires demonstrated a significantly increased cell size. Endothelin-1-treated biowires exhibited increased cardiac troponin secretion into the culture media. This demonstrates that human biowires treated for 7 days with isoproterenol, angiotensin II, or endothelin-1 exhibit some changes compatible with hypertrophic cardiomyopathy.

摘要

动物模型在深入了解疾病的分子基础方面发挥了重要作用。虽然这些信息已成功应用于人类疾病研究,但基于人类细胞的模型若能问世,将极大地增强这种转化研究。这对于心血管疾病尤为重要,因为人类心肌细胞(CMs)的生理学与啮齿动物有显著差异。在此,我们利用人类胚胎干细胞衍生的CMs构建了一种三维人类工程化心脏组织,称为生物线,以研究异丙肾上腺素、内皮素-1或血管紧张素II进行慢性(7天)处理的效果。我们发现,用异丙肾上腺素、内皮素-1或血管紧张素II进行慢性处理的生物线,其肌原纤维排列紊乱,收缩力显著降低。用异丙肾上腺素处理的生物线,脑钠肽和心房钠尿肽基因表达上调。用内皮素-1和血管紧张素II处理的生物线,细胞大小显著增加。用内皮素-1处理的生物线,心肌肌钙蛋白分泌到培养基中的量增加。这表明,用异丙肾上腺素、血管紧张素II或内皮素-1处理7天的人类生物线表现出一些与肥厚型心肌病相符的变化。

相似文献

1
Human Stem Cell-Derived Cardiac Model of Chronic Drug Exposure.人类干细胞来源的慢性药物暴露心脏模型。
ACS Biomater Sci Eng. 2017 Sep 11;3(9):1911-1921. doi: 10.1021/acsbiomaterials.5b00496. Epub 2016 May 10.
2
Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment.肥厚型心肌病的人类工程化心脏组织模型概括了该疾病的关键特征以及慢性玛伐卡坦治疗的效果。
Front Bioeng Biotechnol. 2023 Sep 8;11:1227184. doi: 10.3389/fbioe.2023.1227184. eCollection 2023.
3
Maturation of Human Stem Cell-derived Cardiomyocytes in Biowires Using Electrical Stimulation.利用电刺激在生物丝中使人类干细胞衍生的心肌细胞成熟。
J Vis Exp. 2017 May 6(123):55373. doi: 10.3791/55373.
4
Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.基于人诱导多能干细胞(hiPSC)分化的心肌细胞和心脏细胞外基质构建的工程化心脏组织模型,可用于疾病建模和药物测试应用。
Acta Biomater. 2019 Jul 1;92:145-159. doi: 10.1016/j.actbio.2019.05.016. Epub 2019 May 7.
5
Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle.微加工可灌注心脏生物线:模拟天然心脏束的平台。
Lab Chip. 2014 Mar 7;14(5):869-82. doi: 10.1039/c3lc51123e.
6
Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation.人胚胎干细胞衍生心肌细胞(hESC-CMs)在三维胶原基质中的成熟:微环境细胞补充和机械刺激的影响
Acta Biomater. 2017 Feb;49:204-217. doi: 10.1016/j.actbio.2016.11.058. Epub 2016 Nov 24.
7
DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy.丹红注射液通过作用于内皮素B型受体和血管紧张素II 1型受体来预防心肌肥大。
Oncotarget. 2017 Oct 13;8(61):103393-103409. doi: 10.18632/oncotarget.21900. eCollection 2017 Nov 28.
8
Human Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy.利用诱导多能干细胞创建的人工程心脏组织揭示了BRAF介导的肥厚型心肌病的功能特征。
PLoS One. 2016 Jan 19;11(1):e0146697. doi: 10.1371/journal.pone.0146697. eCollection 2016.
9
Establishing a new human hypertrophic cardiomyopathy-specific model using human embryonic stem cells.利用人类胚胎干细胞建立新的人类肥厚型心肌病特异性模型。
Exp Cell Res. 2020 Feb 1;387(1):111736. doi: 10.1016/j.yexcr.2019.111736. Epub 2019 Nov 20.
10
MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling.MLP 缺陷型人多能干细胞衍生的心肌细胞由于钙处理异常而发展为肥厚型心肌病和心力衰竭表型。
Cell Death Dis. 2019 Aug 13;10(8):610. doi: 10.1038/s41419-019-1826-4.

引用本文的文献

1
Geometrically controlled cardiac microtissues promote vascularization and reduce inflammation and .几何形状受控的心脏微组织促进血管生成并减轻炎症。
Cell Biomater. 2025 May 27;1(4). doi: 10.1016/j.celbio.2025.100075. Epub 2025 Apr 29.
2
Cardiac organ chip: advances in construction and application.心脏器官芯片:构建与应用进展
Biomater Transl. 2024 Nov 15;5(4):411-424. doi: 10.12336/biomatertransl.2024.04.006. eCollection 2024.
3
A framework for developing sex-specific engineered heart models.一种用于开发性别特异性工程心脏模型的框架。
Nat Rev Mater. 2022;7(4):295-313. doi: 10.1038/s41578-021-00381-1. Epub 2021 Oct 20.
4
An Insight on Multicentric Signaling of Angiotensin II in Cardiovascular system: A Recent Update.血管紧张素II在心血管系统中的多中心信号传导洞察:最新进展
Front Pharmacol. 2021 Aug 20;12:734917. doi: 10.3389/fphar.2021.734917. eCollection 2021.
5
Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity.人心肌类器官用于心肌梗死和药物心脏毒性的建模。
Nat Biomed Eng. 2020 Apr;4(4):446-462. doi: 10.1038/s41551-020-0539-4. Epub 2020 Apr 13.
6
Harnessing the Potential of Stem Cells for Disease Modeling: Progress and Promises.利用干细胞进行疾病建模的潜力:进展与前景
J Pers Med. 2020 Feb 6;10(1):8. doi: 10.3390/jpm10010008.
7
Towards chamber specific heart-on-a-chip for drug testing applications.针对药物测试应用的特定心室心脏芯片。
Adv Drug Deliv Rev. 2020;165-166:60-76. doi: 10.1016/j.addr.2019.12.002. Epub 2020 Jan 7.
8
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes.TFPa/HADHA 对于人类心肌细胞中的脂肪酸 β-氧化和心磷脂重塑是必需的。
Nat Commun. 2019 Oct 11;10(1):4671. doi: 10.1038/s41467-019-12482-1.
9
Engineering microenvironment for human cardiac tissue assembly in heart-on-a-chip platform.在心脏芯片平台中构建人心肌组织的工程微环境。
Matrix Biol. 2020 Jan;85-86:189-204. doi: 10.1016/j.matbio.2019.04.001. Epub 2019 Apr 11.